A citation-based method for searching scientific literature

Fleur M van der Valk, Siroon Bekkering, Jeffrey Kroon, Calvin Yeang, Jan Van den Bossche, Jaap D van Buul, Amir Ravandi, Aart J Nederveen, Hein J Verberne, Corey Scipione, Max Nieuwdorp, Leo A B Joosten, Mihai G Netea, Marlys L Koschinsky, Joseph L Witztum, Sotirios Tsimikas, Niels P Riksen, Erik S G Stroes. Circulation 2016
Times Cited: 271



Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2014
Times Cited: 327




List of shared articles



Times cited

Lipoprotein(a).
Florian Kronenberg. Handb Exp Pharmacol 2022
2

Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview.
Ioannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis, Matilda Florentin. Eur J Prev Cardiol 2022
3

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis.
Yannick Kaiser, Nick S Nurmohamed, Jeffrey Kroon, Hein J Verberne, Evangelos Tzolos, Marc R Dweck, Aernout G Somsen, Benoit J Arsenault, Erik S G Stroes, Kang H Zheng,[...]. Heart 2022
9

Lipoprotein(a) Levels at Birth and in Early Childhood: The COMPARE Study.
Nina Strandkjær, Malene Kongsgaard Hansen, Sofie Taageby Nielsen, Ruth Frikke-Schmidt, Anne Tybjærg-Hansen, Børge G Nordestgaard, Ann Tabor, Henning Bundgaard, Kasper Iversen, Pia R Kamstrup. J Clin Endocrinol Metab 2022
7

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, P Barton Duell, Sean P Heffron, Pia R Kamstrup, Donald M Lloyd-Jones, Santica M Marcovina, Calvin Yeang, Marlys L Koschinsky. Arterioscler Thromb Vasc Biol 2022
48

Lipoprotein(a) and aortic valve stenosis: A casual or causal association?
Gloria Santangelo, Andrea Faggiano, Nicola Bernardi, Stefano Carugo, Antonella Giammanco, Pompilio Faggiano. Nutr Metab Cardiovasc Dis 2022
2

Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.
Jiahui Hu, Hao Lei, Leiling Liu, Danyan Xu. Front Cell Dev Biol 2022
1

Lipoprotein(a): An underestimated inflammatory mastermind.
Kim E Dzobo, Jordan M Kraaijenhof, Erik S G Stroes, Nick S Nurmohamed, Jeffrey Kroon. Atherosclerosis 2022
11


Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
Florian Kronenberg, Samia Mora, Erik S G Stroes, Brian A Ference, Benoit J Arsenault, Lars Berglund, Marc R Dweck, Marlys Koschinsky, Gilles Lambert, François Mach,[...]. Eur Heart J 2022
26

Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
Bernhard Zierfuss, Clemens Höbaus, Anna Feldscher, Antonia Hannes, Daniel Mrak, Renate Koppensteiner, Herbert Stangl, Gerit-Holger Schernthaner. Atherosclerosis 2022
0


Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option.
Alessandro Maloberti, Saverio Fabbri, Valentina Colombo, Elena Gualini, Massimiliano Monticelli, Francesca Daus, Andrea Busti, Michele Galasso, Lorenzo De Censi, Michela Algeri,[...]. Int J Mol Sci 2022
0

Lipoprotein(a): Expanding our knowledge of aortic valve narrowing.
Amer Youssef, Justin R Clark, Marlys L Koschinsky, Michael B Boffa. Trends Cardiovasc Med 2021
9

Drugs for Prevention and Treatment of Aortic Stenosis: How Close Are We?
Mehdi Afshar, Shayan Yazdan-Ashoori, James C Engert, George Thanassoulis. Can J Cardiol 2021
5


Lipoprotein (a): When to Measure and How to Treat?
David Rhainds, Mathieu R Brodeur, Jean-Claude Tardif. Curr Atheroscler Rep 2021
3